{Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy}

Citation:

Terpos, E., Kostopoulos, I. V., Kastritis, E., Ntanasis-Stathopoulos, I., Migkou, M., Rousakis, P., Argyriou, A. T., et al. (2019). {Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy}. HemaSphere, 6, 1. presented at the oct. Copy at http://www.tinyurl.com/y4q9x3rv